This is a comparative study between two local anesthetic drugs ; Bupivacaine and Levobupivacaine in surgeries involving lower abdomen and lower limb.

A comparative study of the efficacy of subarachnoid block between hyperbaric Levobupivacaine 0.5% and hyperbaric Bupivacaine 0.5% in patients undergoing lower abdominal and lower limb surgeries - a prospective randomised clinical trial - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/066713

Enrollment

Registered

2024-05-03

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Subarachnoid block anesthesia for lower abdominal and lower limb surgeries: 0.5% Hyperbaric Levobupivacaine (3ml) at L3-L4 intervertebral space for lower abdominal and lower limb surger

Eligibility

Inclusion criteria

Inclusion criteria: 1.American Society of Anaesthesiologists grading I and II 2.Patients giving informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to regional anaesthesia 2.American Society of Anaesthesiologists grading III and IV 3.Coagulation disorder 4.Deformities of vertebral column 5.Allergy to study drugs 6.Morbid obesity 7.Patients with musculoskeletal and psychiatric diseases

Design outcomes

Primary

Measure	Time frame
To estimate the duration of analgesiaTimepoint: 1.Bupivacaine-3hour10mins 2.Levobupivacaine-3hour20mins	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Debarati Goswami

BANKURA SAMMILANI MEDICAL COLLEGE

drsdatta66@gmail.com9433508304

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026